Document Detail


The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: an observational, case-control study.
MedLine Citation:
PMID:  15579750     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In 100 patients with hypopituitarism and 80 sex- and age-matched healthy subjects, we correlated the severity of cardiac impairment to the severity of GH deficiency (GHD). By the GH peak after arginine plus GHRH test (normal > 16.5 microg/liter), the patients were classified as severe GHD (n = 56), partial GHD (n = 27), and non-GHD (n = 17). Compared with controls, decreased left ventricular ejection fraction at rest was found only in severe GHD patients (55.0 +/- 8.8 vs. 63.4 +/- 4.5%, P < 0.001); decreased left ventricular ejection fraction response on effort in severe (-4.6 +/- 17.4 vs. 15.2 +/- 9.1%, P < 0.001) and partial GHD patients (3.6 +/- 6.6 vs. 14.6 +/- 8.3%, P < 0.001); decreased diastolic filling at rest in severe (2.53 +/- 0.68 vs. 3.01 +/- 0.48 end-diastolic volume per second, P < 0.001) and partial GHD (2.61 +/- 0.45 vs. 2.89 +/- 0.54 end-diastolic volume per second, P = 0.004) patients; and decreased exercise duration and capacity in all the patient groups. A normal systolic performance on effort was found in 21.4% of severe GHD, 55.6% of partial GHD, all non-GHD, and 93.7% of controls. A normal diastolic filling at rest was found in 57.1% of severe GHD, 74.1% of partial GHD, 76.5% of non-GHD, and 90% of controls. In conclusion, cardiac performance is correlated with the GH status because significant impairment was found in patients with severe and partial GHD but not in non-GHD hypopituitary patients.
Authors:
Annamaria Colao; Carolina Di Somma; Alberto Cuocolo; Mariagiovanna Filippella; Francesca Rota; Wanda Acampa; Silvia Savastano; Marco Salvatore; Gaetano Lombardi
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  89     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2004 Dec 
Date Detail:
Created Date:  2004-12-06     Completed Date:  2005-02-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5998-6004     Citation Subset:  AIM; IM    
Affiliation:
Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, 80131 Napoli, Italy. colao@unina.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Arginine / diagnostic use
Case-Control Studies
Coronary Circulation
Diastole
Exercise Test
Female
Growth Hormone-Releasing Hormone / diagnostic use
Heart Diseases / diagnosis,  etiology*,  physiopathology*
Hemodynamics
Human Growth Hormone / deficiency*
Humans
Hypopituitarism / complications*
Linear Models
Male
Metabolic Diseases / diagnosis,  etiology*,  physiopathology*
Middle Aged
Severity of Illness Index
Stroke Volume
Systole
Ventricular Function, Left
Chemical
Reg. No./Substance:
12629-01-5/Human Growth Hormone; 74-79-3/Arginine; 9034-39-3/Growth Hormone-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relationship between ghrelin and energy expenditure in healthy young women.
Next Document:  Identification of patients with Cushing's disease with negative pituitary adrenocorticotropin gradie...